mecasermin 10 MG/ML Injectable Solution
- RxCUI
- 604806
- RxNorm name
- mecasermin 10 MG/ML Injectable Solution
- Display name
- mecasermin 10 MG/ML Injectable Solution
- Full name
- mecasermin 10 MG/ML Injectable Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021839 | Increlex | mecasermin | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Increlex | MECASERMIN | Eton Pharmaceuticals, Inc. | d5b2b0e1-c523-468d-9a0b-4ae4e4a8dbce | 2026-05-18 | Warnings, Adverse reactions | 604806 |
| Increlex | MECASERMIN | Ipsen Biopharmaceuticals, Inc. | a8b27a1b-a611-4f91-ad22-76d4b390c3ae | 2025-08-05 | Warnings, Adverse reactions | 604806 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a8b27a1b-a611-4f91-ad22-76d4b390c3ae | mecasermin 10 MG/ML Injectable Solution [PSN] · mecasermin 10 MG/ML Injectable Solution [SCD] | 2 | 21 | These highlights do not include all the information needed to use INCRELEX ® safely and effectively. See full prescribing information for INCRELEX ® . INCRELEX ® (mecasermin) injection, for subcutaneous use Initial U.S. Approval: 2005 | 20250805 |
| d5b2b0e1-c523-468d-9a0b-4ae4e4a8dbce | mecasermin 10 MG/ML Injectable Solution [PSN] · mecasermin 10 MG/ML Injectable Solution [SCD] | 2 | 5 | These highlights do not include all the information needed to use INCRELEX ® safely and effectively. See full prescribing information for INCRELEX ® . INCRELEX ® (mecasermin) injection, for subcutaneous use Initial U.S. Approval: 2005 | 20260518 |